Search - tctmd.com

Displaying 1 - 20 of 100

Sort: Relevancy | Date

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Daily News

Hypothermia Boosts 90-Day Function for Nonshockable Cardiac Arrest

Caitlin E. Cox

December 13, 2019

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

L.A. McKeown

November 26, 2019

News Conference News PCR London Valves 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

News Conference News VEITH 2019

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

L.A. McKeown

November 22, 2019

News Conference News AHA 2019

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

Caitlin E. Cox

November 21, 2019

News Conference News PCR London Valves 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Shelley Wood

November 16, 2019

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Yael L. Maxwell

October 28, 2019

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Caitlin E. Cox

October 04, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

Advertisement

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Hypothermia Boosts 90-Day Function for Nonshockable Cardiac Arrest

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

More Real-world Data Support Safety of Paclitaxel-Based Devices in PAD

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content